TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CalciMedica ( (CALC) ) has issued an announcement.
On January 10, 2025, Eric Bjerkholt resigned from the board of directors and audit committee of CalciMedica, Inc., effective January 15, 2025. His resignation was not due to any disagreements with the company. On January 13, 2025, the board appointed Alan Glicklich, M.D., as a Class I director, effective January 15, 2025, with his term expiring in 2027. Dr. Glicklich’s appointment involves no special arrangements, and he will receive an annual cash retainer and stock options as per company policy.
More about CalciMedica
YTD Price Performance: -11.85%
Average Trading Volume: 62,383
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $40.72M
See more insights into CALC stock on TipRanks’ Stock Analysis page.